摘要
微循环障碍主要是指微血管与微血流水平发生的功能或器质性紊乱,从而引起微循环血液灌注障碍,并导致相应器官组织的功能紊乱和形态学改变。微循环障碍参与了多种疾病的发生发展,既可以是病因,也可以是疾病导致的结果。中医药干预微循环障碍已经得到广泛开展,但多集中在活血化瘀类药物的研究中,如川芎、丹参、以及以活血化瘀药为主组成的中成药,如复方丹参片(滴丸)、心可舒片等。本文综述了近年来非活血化瘀类中药在常见病微循环障碍中已经取得一定成果的研究进展,为进一步开展中医药防治微循环障碍性疾病的研究开辟新思路和新途径。
Microcirculatory disorders mainly refer to functional or organic disorders of microvascular and microvascular levels,which cause disorders of microcirculatory blood perfusion and lead to dysfunction and morphological changes in the corresponding organ tissues.It is involved in the development of a variety of diseases,both as a cause and as a result of multiple diseases.Traditional Chinese medicine intervention for microcirculatory disorders has been widely carried out,but most of them are concentrated in the study of blood-activating and phlegm-removing drugs,such as Chuanxiong,Salvia miltiorrhiza,and Chinese patent medicines consisting mainly of activating blood and removing stasis drugs,such as Fufang Danshen Tablets(drip pills),Xin Keshu,etc.This article reviews the research progress of related microcirculation disorders such as cardiovascular and cerebrovascular diseases in recent years,and the research progress of non-activating blood stasis and traditional Chinese medicines in disease microcirculation disorders,in order to further develop traditional Chinese medicine prevention and treatment microcirculation.
作者
刘燕君
胡镜清
呼思乐
陈彦静
LIU Yan-jun;HU Jin-qing;HU Si-le;CHEN Yan-jin(Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medicine Science,Beijing 100700,China)
出处
《微循环学杂志》
2019年第4期78-82,82,共5页
Chinese Journal of Microcirculation
基金
中国中医科学院中医药"一带一路"合作专项(GH2017-02-03)
关键词
非活血化瘀
微循环障碍
常见疾病
中医药
Non-promoting blood circulation therapy
Microcirculatory disorders
Common diseases
Traditional Chinese medicine